Centre Testing International Group (300012) Q3 2026 earnings summary

Executive summary

• Q3 revenue was RMB 1,990,373,891.05, up 14.27% YoY; attributable net income was RMB 395,057,360.40, up 14.52% YoY.

• 9M revenue rose 15.27% YoY to RMB 5,419,767,142.15; attributable net income increased 18.04% to RMB 958,741,147.43.

• Q3 financial statements were unaudited.

Financial highlights

• 9M adjusted attributable net income, excluding non-recurring items, was RMB 912,298,493.90, up 19.09% YoY; Q3 adjusted net income was RMB 383,639,604.82, up 17.44%.

• 9M net income was RMB 966,767,114.91 versus RMB 809,990,773.86 YoY; operating profit was RMB 1,081,861,119.14.

• 9M non-recurring gains, net of tax and minority interests, totaled RMB 46,442,653.53, including RMB 43,545,870.17 in government grants.

• Other income increased 30.46% YoY to RMB 43,545,870.23; fair-value gains rose to RMB 5,327,898.95 from RMB 674,889.70.

Key financial ratios and metrics

• 9M basic and diluted EPS were RMB 0.5712, up 17.65% YoY; Q3 EPS was RMB 0.2349, up 13.92%.

• 9M EBITDA was RMB 1,527,163,948.39, up 15.61% YoY; Q3 EBITDA was RMB 591,881,492.06, up 12.68%.

• 9M weighted average ROE was 11.88%, up 0.31 percentage points YoY; Q3 ROE was 4.74%, up 0.06 percentage points.

• Total assets reached RMB 11,082,112,287.19 at Sept. 30, up 6.77% from year-end; attributable equity was RMB 8,399,905,582.55, up 9.47%.